Drugs firm examined by regulator after ‘shocking’ safety breaches

The Health Products Regulatory Authority (HPRA) said it was concerned and was “following up with" drug maker Astellas

Ireland’s medicines regulator is assessing the possible implications for Ireland after the drugmaker Astellas was accused of “shocking” breaches of guidelines that “raised serious concerns with regard to patient safety” in Britain.

In a statement to this newspaper last week, the Health Products Regulatory Authority (HPRA) said it was concerned and was “following up with Astellas as regards any possible implications for the advertising and promotion of the company’s medicines in Ireland”.

The ...